Neuraminidase treated cells and their role in cancer immunotherapy
Simmons, R.L.; Rios, A.
Birth Defects Original Article Series 9(2): 223-228
1973
ISSN/ISBN: 0547-6844 PMID: 4611534 Document Number: 63301
Document emailed within 1 workday
Related Documents
Ogasawara, M.; Takebe, T.; Ishii, K. 1988: Tumor-associated antigen defined by a monoclonal antibody against neuraminidase-treated human cancer cells Cancer Research 48(2): 412-417Bratus', G.G.; Naumenko, O.I.; Nastenko, E.P.; Novichenko, N.L. 1990: The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin a and Vibrio cholerae neuraminidase Tsitologiia 32(1): 67-73
Ray, P.K.; Gewurz, H.; Simmons, R.L. 1972: The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity Clinical and Experimental Immunology 11(3): 441-460
Rios, A.; Simmons, R.L. 1973: Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells Journal of the National Cancer Institute 51(2): 637-644
Ray, R.K.; Simmons, R.L. 1973: Differential release of sialic acid from normal and malignant cells by Vibrio cholerae neuraminidase or influenza virus neuraminidase Cancer Research 33(5): 936-939
Luther, P.; Klamm, H.; Weber, S. 1983: Simple detection of mumps virus neuraminidase and anti-neuraminidase with the lectin neuraminidase test Acta Virologica 27(1): 89-91
Rogowski, W. 1997: The role of potential duplication of time for the neoplastic cells in patients with head and neck cancer treated by radiation Otolaryngologia Polska 51(6): 531-536
Iantorno, R.; Nicolai, M.; Cipollone, G.; Di Federico, G.; Tenaglia, R. 1997: Role of MCP-1 chemokine in the response of monocytes of patients with superficial tumors of the bladder treated with BCG immunotherapy Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 69(Suppl 1): 71-72
Sedlacek, H.H.; Seiler, F.R. 1977: Spontaneous mammary tumors in mongrel dogs. a relevant model to demonstrate tumor therapeutical success by application of neuraminidase-treated tumor cells Developments in Biological Standardization 38: 399-412
Okita, R.; Yamaguchi, Y.; Ohara, M.; Hironaka, K.; Okawaki, M.; Nagamine, I.; Ikeda, T.; Emi, A.; Hihara, J.; Okada, M. 2009: Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer International Journal of Oncology 34(2): 563-572
Sparks, F.C.; Breeding, J.H. 1974: Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase Cancer Research 34(12): 3262-3269
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113
Bereznaya, N.M.; Chekhun, V.F. 2007: Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy Experimental Oncology 29(1): 2-12
Arlen, P.M. 2011: Prostate cancer immunotherapy: the role for sipuleucel-T and other immunologic approaches Oncology 25(3): 261-262
Kowalczyk, D.W.; Wysocki, P.J.; Mackiewicz, A. 2003: Cancer immunotherapy using cells modified with cytokine genes Acta Biochimica Polonica 50(3): 613-624
Kodama, I.; Aoyagi, K.; Tanaka, T.; Kumegawa, H.; Ohta, J.; Maruiwa, M.; Kofuji, K.; Takeda, J.; Kakegawa, T. 1993: A case of advanced gastric cancer with liver and lung metastasis effectively treated by combined chemo-immunotherapy of MMC, 5'-DFUR, OK-432 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(9): 1237-1240
Markowicz, S.; Niedzielska, J.; Kruszewski, M.; Ołdak, T.; Gajkowska, A.; Machaj, E.K.; Skurzak, H.; Pojda, Z. 2006: Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy Acta Biochimica Polonica 53(1): 203-212
Wada, J.; Yamasaki, A.; Nagai, S.; Yanai, K.; Fuchino, K.; Kameda, C.; Tanaka, H.; Koga, K.; Nakashima, H.; Nakamura, M.; Tanaka, M.; Katano, M.; Morisaki, T. 2008: Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients Anticancer Research 28(4c): 2401-2408
Padmanabhan, T.K.; Balaram, P.; Vasudevan, D.M. 1987: Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. a three-year clinical follow up Neoplasma 34(5): 627-632
2016: New immunotherapy uses defense cells against hematologic cancer. "Living medicine instead of roentgen rays Pflege Zeitschrift 69(6): 323